Precision Biosensor

Precision Biosensor Earnings Yield

The Earnings Yield of Precision Biosensor (335810.KQ) as of Oct 28, 2026 is -21.10 %. In the previous year, Earnings Yield was -15.38 % — a change of 37.20% (lower).

Earnings Yield

-21.10 %

YoY

37.20%

Last updated:

Earnings Yield of Precision Biosensor is 2025 -21.10 % . Earnings Yield of Precision Biosensor was 2024 -15.38 % . It decreases by 37.20% lower compared to the previous year.

The Precision Biosensor Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-8.51 KRW
Jan 1, 2019
-0.85 KRW
Jan 1, 2020
-10.43 KRW
Jan 1, 2021
-8.74 KRW
Jan 1, 2022
-14.33 KRW
Jan 1, 2023
-9.45 KRW
Jan 1, 2024
-15.38 KRW
Jan 1, 2025
-21.10 KRW
The Precision Biosensor Earnings Yield history
YEAREarnings YieldYoY
-21.10 %+37.20%
-15.38 %+62.69%
-9.45 %-34.02%
-14.33 %+63.91%
-8.74 %-16.17%
-10.43 %+1,121.93%
-0.85 %-89.97%
-8.51 %+64.56%
-5.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Precision Biosensor Stock analysis

What does Precision Biosensor do? Precision Biosensor Inc. generates revenue through the sale of portable immunoassay diagnostic devices and cartridges. The testers, which are portable devices using colorimetric and time-resolved fluorescence, are sold for on-site diagnosis of acute heart disease, metabolism, and inflammatory diseases. The cartridges, designed for gold absorption and time-resolved fluorescence analysis, are used in diagnostic equipment to check the same conditions. The company targets domestic and overseas markets including Europe, China, the Middle East, and Southeast Asia for its products. The firm's primary customers are healthcare providers and diagnostic laboratories seeking rapid, on-site testing solutions. These segments value the portability and speed of the testers, which enable immediate diagnosis without laboratory processing. The cartridges complement the testers by providing consumable components for consistent diagnostic accuracy across various medical conditions. Precision Biosensor Inc. focuses on markets where demand for point-of-care diagnostics is growing, particularly in regions with expanding healthcare infrastructure. The company's product line addresses acute heart disease, metabolism, and inflammatory diseases, aligning with global health priorities. Sales in Europe, China, the Middle East, and Southeast Asia reflect the company's strategy to serve both developed and emerging healthcare systems. Precision Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Precision Biosensor stock

Earnings Yield of Precision Biosensor is -21.10 % in 2025.

Earnings Yield of Precision Biosensor changed from -15.38 % to -21.10 %, representing a 37.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Precision Biosensor since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Precision Biosensor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Precision Biosensor

All Key Metrics — Precision Biosensor